Recent Blog Articles

Close relationships with neighbors influence cardiovascular health in Black adults

Why play? Early games build bonds and brain

5 numbers linked to ideal heart health

Rating the drugs in drug ads

Postpartum anxiety is invisible, but common and treatable

The popularity of microdosing of psychedelics: What does the science say?

Pouring from an empty cup? Three ways to refill emotionally

Is pregnancy safe for everyone?

New pediatric guidelines on obesity in children and teens

Screening tests may save lives — so when is it time to stop?

Mark Benson, MD, PhD
Contributor
Mark D. Benson, M.D., Ph.D. is the Director of Preventive Cardiology at Beth Israel Deaconess Medical Center (BIDMC). He is also a basic and translational researcher in the field.
Dr. Benson received his B.A. in biological sciences from Columbia University and his M.D. and Ph.D. in pharmacology from the University of Michigan. He completed his residency training in internal medicine at the University of Michigan, his fellowship training in cardiology at Brigham and Women’s Hospital, and his post-doctoral training in multi-omics research at BIDMC.
Dr. Benson is a principal investigator at the CardioVascular Institute at BIDMC. His laboratory’s interests are focused on applying emerging metabolomics, proteomics, and genomics technologies to detect signatures of small molecules in blood that may be used to predict an individual’s future risk of developing cardiovascular disease. The ultimate goal of this research is to identify novel biomarkers and pharmacological targets that may improve preventive cardiovascular disease therapy.